Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The survival rate in patients with systemic lupus erythematosus (SLE) has improved dramatically during the past four decades to 96.6% (five year) in the Erlangen cohort, but it is nearly three times as high as in an age and sex matched control population. Reasons for death are mainly cardiovascular diseases (37%) and infections (29%).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann Rheum Dis

Title: Annals of the rheumatic diseases

Publisher: BMJ

ISSN: 0003-4967

ISSN (Print): 0003-4967

Publication date (Electronic): Dec 2002

Volume: 61

Issue: 12

Affiliations

[1 ] Department of Internal Medicine III and Institute for Clinical Immunology, University Erlangen-Nuremberg, Germany Department of Medical Informatics, Biometry and Epidemiology, University Erlangen-Nuremberg, Germany. karin.manger@med3.imed.uni-erlangen.de

Article

DOI: 10.1136/ard.61.12.1065

PMC ID: 1753955

PubMed ID: 12429536

SO-VID: 5707cf74-4a6b-4086-98ae-f31f6ee96e68

History

Data availability:

Comments

Comment on this article

scite_

Cited by 37

See all cited by

- Version 1
- Version 1